Dapoxetine hydrochloride: Treatment of premature ejaculation 5-HT reuptake inhibitor

Drugs of the Future

Volumn 29, Issue 12, 2004, Pages 1201-1205

  Sorbera, L A ^a   Castaner J ^a   Castaner R M ^a  

^a PROUS SCIENCE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANTICONVULSIVE AGENT; BENZODIAZEPINE DERIVATIVE; CLOMIPRAMINE; CLONAZEPAM; DAPOXETINE; FLUOXETINE; GABAPENTIN; PLACEBO; PRAZOSIN; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

AREA UNDER THE CURVE; ARTICLE; BEHAVIOR THERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG HALF LIFE; DRUG METABOLISM; DRUG SAFETY; DRUG STRUCTURE; DRUG TOLERABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MOUSE; MULTICENTER STUDY; NAUSEA; NONHUMAN; PHASE 1 CLINICAL TRIAL; PREMATURE EJACULATION; RANDOMIZED CONTROLLED TRIAL; RAT;

EID: 13544259815     PISSN: 03778282     EISSN: None     Source Type: Journal    
DOI: 10.1358/dof.2004.029.12.865936     Document Type: Article

References (22)

1. 14C isotopomer. J Label Compd Radiopharm 1992, 31: 305-15.
2. Robertson, D.W., Thompson, D.C., Wong, D.T. (Eli Lilly and Company). 1-Phenyl-3-naphthalenyloxypropanamines. AU 8814335, EP 0288188, US 5135947, JP 1988258837.
3. Alt, C.A., Robey, R.L., Van Meter, E.E. (Eli Lilly and Company). Intermediates to 1-phenyl-3-naphthalenyloxy-propanamines. US 5292962.
4. Prous Science R&D Backgrounders: Male and female sexual dysfunction (online publication). Updated December 21, 2004.
5. Waldinger, M.D. The neurobiological approach to premature ejaculation. J Urol 2002, 168: 2359-67.
6. Waldinger, M.D. Chapter 15: Rapid ejaculation. In: Handbook of Clinical Sexuality for Mental Health Professionals. S.B. Levine, C.B. Risen and S.E. Althof (Eds.), Brunner-Routledge, New York, 2003, 257-74.
7. Waldinger, M.D., Berendsen, H.H., Blok, B.F., Olivier, B., Holstege, G. Premature ejaculation and serotonergic antidepressants-induced delayed ejaculation: The involvement of the serotonergic system. Behav Brain Res 1998, 92: 111-8.
8. Waldinger, M.D., Olivier, B. Selective serotonin reuptake inhibitor-induced sexual dysfunction: Clinical and research considerations. Int Clin Psychopharmacol 1998, 13(Suppl. 6): S27-33.
9. Olivier, B., van Oorschot, R., Waldinger, M.D. Serotonin, serotonergic receptors, selective serotonin reuptake inhibitors and sexual behaviour. Int Clin Psychopharmacol 1998, 13(Suppl. 6): S9-14.
10. Waldinger, M.D., Rietschel, M., Nothen, M.M., Hengeveld, M. W., Olivier, B. Familial occurrence of primary premature ejaculation. Psychiatr Genet 1998, 8: 37-40.
11. Waldinger, M.D. Lifelong premature ejaculation: From authority-based to evidence-based medicine. BJU Int 2004, 93: 201-7.
12. Waldinger, M.D., Zwinderman, A.M., Schweitzer, D.H., Olivier, B. Relevance of methodological design for the interpretation of efficacy of drug treatment of premature ejaculation: A systematic review and meta-analysis. Int J Impot Res 2004, 16: 369-81.
13. Chue, P. Gabapentin treatment for premature ejaculation. Can J Psychiatry 2004, 49: 644-5.
14. 11C]dapoxetine.HCl, a serotonin reuptake inhibitor: Biodistribution in rat and preliminary PET imaging in the monkey. Nucl Med Biol 1994, 21: 669-75.
15. 14C-dapoxetine in rats: Complementary experiments with whole-body autoradiographic and tissue dissection techniques. Biopharm Drug Dispos 1994, 15: 137-50.
16. Franklin, R.B., Manzione, B.M., Wrighton, S.A. Metabolism of the serotonin-reuptake inhibitor, LY210448 in several animal species. Pharmacologist 1991, 33(3): Abst 109.
17. Manzione, B.M., Franklin, R.B. Metabolism and disposition of the serotonin reuptake inhibitor, LY2W448 hydrochloride in mice, rats, and dogs. Pharmacologist 1990, 32(3): Abst 31.
18. Hamilton, C.L., Cornpropst, J.D. Determination of dapoxetine, an investigational agent with the potential for treating depression, and its mono- and di-desmethyl metabolites in human plasma using column-switching high-performance liquid chromatography. J Chromatogr - Biomed Appl 1993, 612: 253-61.
19. Seger, M.E., Bergstrom, R.F., Schwertschlag, U.S., DeLong, A. F. Pharmacokinetics of dapoxetine after single oral doses given during a phase I clinical evaluation. Pharm Res 1992, 9(10, Suppl.): Abst PPDM 8212.
20. Dresser, M., Lindert, K., Lin, D., Gidwani, S., Gupta, S.K., Modi, N.B. Pharmacokinetics of single and multiple escalating doses of dapoxetine in healthy volunteers. Clin Pharmacol Ther 2004, 75(2): Abst PI-113.
21. Hellstrom, W., Gittelman, M., Althof, S., Ho, K.F., Kell, S. Dapoxetine HCl for the treatment of premature ejaculation: A phase II, randomized, double-blind, placebo-controlled study. J Sex Med 2004, 1(Suppl. 1): Abst O97.
22. Who wants to talk about premature ejaculation? Ortho-McNeil News Release May 10, 2004.